The global disposable bronchoscopes market size was valued at USD 506.4 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 13.4% from 2022 to 2028. Transitioning from traditional open surgeries to minimally invasive procedures for diagnostic and therapeutic purposes is driving the growth of the market. Furthermore, the increasing incidence of lung cancer, high demand for local biopsies, growing geriatric population, and technological advancements in the field of bronchoscopy devices are bolstering the market growth. High prevalence of chronic respiratory disorders, such as lung cancer, tumors airway stenosis, pneumonia, bronchitis, lung infections, and chronic obstructive Pulmonary Disease (COPD), is also driving the product demand for therapeutics & diagnostics purposes to obtain tissue specimens of the lung and view abnormalities & assess growths in the airway.
As per the World Health Organization (WHO) estimates, 3.3 million individuals annually succumb to COPD. Furthermore, as per the American Cancer Society estimates, in 2018, 235,070 new cases of lung cancer and tumors were detected in the U.S., thereby boosting the demand for bronchoscopies for biopsies to detect and treat lung cancers.
In addition, as per Cancer Research U.K., 47,800 new lung cancer cases are diagnosed annually. As per the World Cancer Research Fund International, developing countries account for 58.7% of lung cancer cases. The above alarming incidence rates are anticipated to drive the product demand across the globe. Healthcare professionals are rapidly utilizing disposable bronchoscopes in diagnosing or treating respiratory ailments as it enables minimal intervention and shortens the recovery time. The development of single-use bronchoscopes to avoid the incidence of infections is also one of the key trends expected to drive the market. An increase in research initiatives focused on analyzing the efficacy of endoscopic treatments for non-cancerous diseases is also propelling the market.
Moreover, the growing global geriatric population is expected to support market growth. As per the Administration on Aging (AoA), in 2019, 16% of the U.S. population was aged 65 years & above and is expected to reach 21.6% by 2040. The growing trend of minimally invasive procedures in assessing the airway and tracheobronchial tree for respiratory tract diseases coupled with new product approvals is driving the market growth. For instance, in August 2021, Boston Scientific received U.S. FDA clearance for disposable bronchoscopes, eliminating the risk of infection usually associated with reusable bronchoscopes.
The rising preference for minimally invasive procedures is associated with their benefits, such as higher patient satisfaction, economic viability, shortened hospitalization, and reduced post-procedural complications. The risk of infection and contamination in using reusable bronchoscopes is presenting growth opportunities to the market. The COVID-19 pandemic significantly impacted the bronchoscopy market and disrupted workflows across the entire healthcare industry. Several bronchoscopy procedures, such as visualization and documentation systems, witnessed a negative impact due to the pandemic.
Pandemic Impact |
Post COVID Outlook |
The global market increased by 24.4% from 2019 to 2020 |
The market is estimated to witness a yo-y growth of 15.9% to 28.9% in the next 5 years |
Healthcare professionals’ awareness levels towards infection and contamination risks associated with using reusable devices grew during the pandemic and prioritization of emergent procedures drove the healthcare fraternity to adopt disposable bronchoscopes |
Market players are focusing on product innovation and development in the disposable devices space to curb the contamination risks. For instance, in August 2021, Boston Scientific Corp. received U.S. FDA clearance for its EXALT Model B, disposable bronchoscope |
The benefits associated with disposable devices, such as economic viability, shortened hospitalization, quicker recovery time, and reduced postoperative care, are driving the product adoption rate |
Market players are actively investing in R&D and product innovation cycles to develop disposable bronchoscopes. Some of the leading players in this space are Boston Scientific Corp., AMBU A/S, and Olympus. |
Bronchoscopy procedures involve a high amount of risk owing to the increased pressures used to oxygenate the patient, detectible disruption of respiratory tract mucosa, close contact between a healthcare professional & patient, and generation of significant amounts of droplets & aerosols, which can contaminate procedure room equipment, personnel, and present infection risk. Although there are risks associated with bronchoscopy procedures, they remain vital and imperative procedures in diagnosis and treating respiratory diseases and cannot be postponed in certain instances. The pandemic challenged the prioritization of patients requiring prompt bronchoscopies. Lastly, the changing regulations about surgical procedures and supply chain disruptions are some of the factors that challenged the market growth during the pandemic.
In 2021, the hospital's segment accounted for the highest market share of 47.4% owing to the significant product adoption & utilization rate in hospitals compared to other healthcare facilities. In addition, the growing favorable reimbursement policies and advancing healthcare infrastructure in developed & emerging economies are driving the segment growth. Hospitals are regarded as the primary health systems across several countries and account for the highest number of procedures & surgeries, which also drives the segment growth. Growing awareness levels about contamination risks and hospital-acquired infections associated with reusable devices are contributing to the high product demand in hospitals.
On the other hand, the clinics' segment is anticipated to register the fastest CAGR over the forecast years. Cost-effectiveness associated with disposable bronchoscopes compared to reusable devices is driving the adoption rate of these devices in clinics. Shortened procedure time, minimal discomfort, enhanced patient satisfaction, reduced postoperative care, and quicker recovery time are among the other benefits driving the adoption of these devices in clinics. Moreover, the growing trend of same-day surgeries is expected to propel the growth of the clinics' segment over the forecast period.
North America dominated the global market with a revenue share of 41.7% in 2021. The high share was attributed to the rapid adoption of advanced technologies, demand for minimally invasive procedures, growing geriatric population, rising prevalence of chronic respiratory disorders, and advancing healthcare infrastructure in the region. The presence of several key manufacturers, suppliers, & distributors and regulatory approvals for disposable bronchoscopes is driving the growth.
On the other hand, Asia Pacific is anticipated to register the fastest growth rate over the forecast period owing to the improving healthcare infrastructure, substantial economic development, presence of lesser regulatory frameworks, growing geriatric population, and rising prevalence of lung cancers & COPD. Moreover, the increasing opportunities associated with minimally invasive procedures are attracting international investments in the region. The presence of key players with the developing startup landscape is also driving the APAC regional market growth.
The market is highly competitive due to the rising product demand for diagnosing and treating several lung disorders. Advancements in the market and constant product approvals from regulatory authorities are driving the market. Some of the key players operating in the global disposable bronchoscopes market are:
Olympus Corp.
AMBU A/S
Boston Scientific Corp.
Smith & Nephew, Inc.
NeoScope, Inc.
Pentax Medical
Karl Storz SE & Co.
Fujifilm Corp.
Report Attribute |
Details |
Market size value in 2022 |
USD 595.1 million |
Revenue forecast in 2028 |
USD 1.3 billion |
Growth rate |
CAGR of 13.4% from 2021 to 2028 |
Base year for estimation |
2021 |
Historical data |
2014 - 2020 |
Forecast period |
2022 - 2028 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2022 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
End-use,region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; Spain; France; Italy; Russia; Switzerland; Denmark; China; Japan; India; Australia; New Zealand; Thailand; Indonesia; Malaysia; Vietnam; Philippines; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait; Israel; Qatar |
Key companies profiled |
Olympus Corp.; FUJIFILM Holdings Corp.; Stryker Corp.; Boston Scientific Corp.; Karl Storz GmbH & Co. KG.; Smith & Nephew, Inc.; Richard Wolf GmbH; PENTAX Medical; AMBU A/S; NeoScope Inc |
Customization scope |
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global disposable bronchoscopes market report on the basis of end use and region:
End-use Outlook (Revenue, USD Million, 2014 - 2028)
Hospitals
Clinics
Diagnostics Centers
Regional Outlook (Revenue, USD Million, 2014 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
Italy
France
Spain
Russia
Switzerland
Denmark
Asia Pacific
Australia
China
Japan
Australia
New Zealand
Thailand
Indonesia
Malaysia
Vietnam
Philippines
Latin America
Mexico
Brazil
Argentina
Middle East Africa
South Africa
Saudi Arabia
UAE
Kuwait
Israel
Qatar
b. The global disposable bronchoscopes market size was estimated at USD 506.4 million in 2021 and is expected to reach USD 595.1 million in 2022.
b. The global disposable bronchoscopes market is expected to grow at a compound annual growth rate of 13.4% from 2022 to 2028 to reach USD 1.3 billion by 2028.
b. North America dominated the disposable bronchoscopes market with a revenue share of 41.7% in 2021. The high share is attributable to rapid adoption of advanced technologies, growing trend of minimally invasive procedures, growing geriatric population, rising prevalence of chronic respiratory disorders, and advancing healthcare infrastructure
b. Some of the key market players are Olympus Corporation, AMBU A/S, Boston Scientific Corporation, Smith & Nephew Inc, NeoScope Inc, Pentax Medical, Karl Storz SE & Co., and Fujifilm Corporation.
b. Some of the key factors impacting the disposable bronchoscopes market growth include the increasing incidence of lung cancer, growing demand for local biopsies, growing geriatric population coupled with rising prevalence of chronic respiratory disorders, and technological advancements in the field of bronchoscopy devices
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.